Beyond the Gut: A Case Report of Antibiotic-Induced Dysbiosis as a Hidden Cause of Chronic Insomnia
Abstract
Insomnia is a common sleep disorder that affects many adults on a long-term or intermittent basis. While conventional management includes pharmacotherapy and cognitive behavioral therapy, emerging evidence highlights the gut microbiome as a critical regulator of sleep via the microbiome-gut-brain axis. Prolonged antibiotic exposure can lead to an alteration or imbalance in the structure, composition, and function of the gut microbial community, known as gut dysbiosis. Gut dysbiosis may disrupt neurotransmitter synthesis and circadian rhythm, contributing to refractory insomnia. We report a 40-year-old man with early T-cell precursor acute lymphoblastic leukemia who underwent induction chemotherapy and allogeneic stem cell transplantation. Over two years, he received multiple prolonged antibiotic courses for infectious complications, resulting in significant cumulative exposure. Several months later, he developed severe insomnia, unresponsive to melatonin, mirtazapine, CBT-I, and multiple hypnotics, including zolpidem and lemborexant. Actigraphy revealed sleep latency of 90 minutes, total sleep time <4 hours, and sleep efficiency of 50-55%. Integrative evaluation demonstrated marked gut dysbiosis (low Firmicutes/Bacteroidetes ratio, overgrowth of Streptococcus, Klebsiella, Fusobacterium) and multiple micronutrient deficiencies. Targeted interventions, multistrain probiotics, fermented foods, high-fiber diet, and amino acid/vitamin supplementation, led to progressive…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.